698358-03-1Relevant articles and documents
Plasma stability-dependent circulation of acyl glucuronide metabolites in humans: How circulating metabolite profiles of muraglitazar and peliglitazar can lead to misleading risk assessment
Zhang, Donglu,Raghavan, Nirmala,Wang, Lifei,Xue, Yongjun,Obermeier, Mary,Chen, Stephanie,Tao, Shiwei,Zhang, Hao,Cheng, Peter T.,Li, Wenying,Ramanathan, Ragu,Yang, Zheng,Griffith Humphreys
, p. 123 - 131 (2011)
Muraglitazar and peliglitazar, two structural analogs differing by a methyl group, are dual peroxisome proliferator-activated receptor- α/γ activators. Both compounds were extensively metabolized in humans through acyl glucuronidation to form 1-O-β-acyl g
The practical synthesis of β-acyl glucuronides by using allyl 2,3,4-tri-(O-allyloxycarbonyl)-D-glucuronate and 1-chloro-N,N,2-trimethyl-1-propenylamine
Nagao, Muneki,Suzuki, Masashi,Takano, Yasuo
supporting information, p. 3339 - 3343 (2016/07/11)
We described the practical synthesis of β-acyl glucuronide from allyl 2,3,4-tri-(O-allyloxycarbonyl)-D-glucuronate (5) mediated by 1-chloro-N,N,2-trimethyl-1-propenylamine (TMCE). A wide range of bulky carboxylic acids (aryl carboxylic acids or tertiary-carbon-linked carboxylic acids) were employed to give the corresponding β-acyl glucuronate in good yields. The side products of this reaction are only N,N-dimethylisobutyramide and HCl. As the resulting acyl glucuronates show sufficient solubility to organic solvent, it can be easily purified by conventional silica gel column chromatography and/or crystallization, even in multigram quantities. The allyloxycarbonyl group and allyl group are cleanly removed by Pd(0), and thus the protocol can provide multigram quantities of β-acyl glucuronides with high purity.
Synthesis of three isotopically labeled versions and a metabolite of Aurora A kinase inhibitor
Li, Yuexian,Prakash, Shimoga R.
experimental part, p. 355 - 359 (2011/07/08)
Sodium ring-[14C]-4-[[9-chloro-7-(2,6-difluorophenyl)-5H- pyrimido[5,4-d][2]benzazepin-2-yl]amino]-benzoate (1A, MLN8054), an Aurora A kinase inhibitor, was synthesized from [14C]-cyanamide in two steps in an overall radiochemical yi